121 related articles for article (PubMed ID: 9886794)
1. Anti-GM1, anti-central myelin proteins, and anti-cardiolipin autoantibodies during plasma-exchange in Guillain-Barré syndrome (GBS).
Matà S; Avanzi G; Lombardo R; Cepparone F; Pinto F; Lolli F
J Clin Apher; 1998; 13(4):155-62. PubMed ID: 9886794
[TBL] [Abstract][Full Text] [Related]
2. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
3. Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barré syndrome.
Press R; Matá S; Lolli F; Zhu J; Andersson T; Link H
J Neurol Sci; 2001 Sep; 190(1-2):41-7. PubMed ID: 11574105
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies to peripheral nerve glycosphingolipids SPG, SLPG, and SGPG in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Yuki N; Tagawa Y; Handa S
J Neuroimmunol; 1996 Oct; 70(1):1-6. PubMed ID: 8862128
[TBL] [Abstract][Full Text] [Related]
5. The presence of Mycoplasma pneumoniae infection and GM1 ganglioside antibodies in Guillain-Barré syndrome.
Sharma MB; Chaudhry R; Tabassum I; Ahmed NH; Sahu JK; Dhawan B; Kalra V
J Infect Dev Ctries; 2011 Jul; 5(6):459-64. PubMed ID: 21727645
[TBL] [Abstract][Full Text] [Related]
6. ELISA-type titertray assay of IgM anti-GM1 autoantibodies.
Bech E; Jakobsen J; Orntoft TF
Clin Chem; 1994 Jul; 40(7 Pt 1):1331-4. PubMed ID: 8013109
[TBL] [Abstract][Full Text] [Related]
7. IgM anti-GM1 antibodies in the Guillain-Barré syndrome: a serological predictor of the clinical course.
Bech E; Orntoft TF; Andersen LP; Skinhøj P; Jakobsen J
J Neuroimmunol; 1997 Jan; 72(1):59-66. PubMed ID: 9003245
[TBL] [Abstract][Full Text] [Related]
8. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis.
Vriesendorp FJ; Mishu B; Blaser MJ; Koski CL
Ann Neurol; 1993 Aug; 34(2):130-5. PubMed ID: 8338337
[TBL] [Abstract][Full Text] [Related]
9. Anti-GM1 antibodies in patients with Guillain-Barré syndrome.
van den Berg LH; Marrink J; de Jager AE; de Jong HJ; van Imhoff GW; Latov N; Sadiq SA
J Neurol Neurosurg Psychiatry; 1992 Jan; 55(1):8-11. PubMed ID: 1548508
[TBL] [Abstract][Full Text] [Related]
10. Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Simone IL; Annunziata P; Maimone D; Liguori M; Leante R; Livrea P
J Neurol Sci; 1993 Jan; 114(1):49-55. PubMed ID: 8433097
[TBL] [Abstract][Full Text] [Related]
11. High and Persistent Anti-GM1 Antibody Titers Are Associated With Poor Clinical Recovery in Guillain-Barré Syndrome.
Thomma RCM; Fokke C; Walgaard C; Vermeulen-de Jongh DMC; Tio-Gillen A; van Rijs W; van Doorn PA; Huizinga R; Jacobs BC
Neurol Neuroimmunol Neuroinflamm; 2023 Jul; 10(4):. PubMed ID: 37059469
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features.
Gregson NA; Koblar S; Hughes RA
Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986
[TBL] [Abstract][Full Text] [Related]
13. [Guillain-Barré syndrome with high titers of anti-GM2 and anti-GalNAc-GD1a antibody following cytomegalovirus hepatitis].
Shimoya K; Ohnishi A; Hashimoto T; Yuki N
Rinsho Shinkeigaku; 1997 Feb; 37(2):106-10. PubMed ID: 9164140
[TBL] [Abstract][Full Text] [Related]
14. Binding of immunoglobulin G antibodies in Guillain-Barré syndrome sera to a mixture of GM1 and a phospholipid: possible clinical implications.
Kusunoki S; Morita D; Ohminami S; Hitoshi S; Kanazawa I
Muscle Nerve; 2003 Mar; 27(3):302-6. PubMed ID: 12635116
[TBL] [Abstract][Full Text] [Related]
15. Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome.
Schessl J; Koga M; Funakoshi K; Kirschner J; Muellges W; Weishaupt A; Gold R; Korinthenberg R
Arch Dis Child; 2007 Jan; 92(1):48-52. PubMed ID: 16920757
[TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of serum antibodies to GD1b in immune-mediated neuropathies.
Taams NE; Notermans NC; Fokkink WR; Tio-Gillen AP; Huizinga R; Schreurs MWJ; Jacobs BC
J Peripher Nerv Syst; 2018 Dec; 23(4):227-234. PubMed ID: 30101437
[TBL] [Abstract][Full Text] [Related]
17. Seroreactivity to Campylobacter jejuni and gangliosides in patients with Guillain-Barré syndrome.
von Wulffen H; Hartard C; Scharein E
J Infect Dis; 1994 Oct; 170(4):828-33. PubMed ID: 7930724
[TBL] [Abstract][Full Text] [Related]
18. N-glycolylneuraminic acid-containing GM1 is a new molecule for serum antibody in Guillain-Barré syndrome.
Odaka M; Yuki N; Yoshino H; Kasama T; Handa S; Irie F; Hirabayashi Y; Suzuki A; Hirata K
Ann Neurol; 1998 Jun; 43(6):829-34. PubMed ID: 9629854
[TBL] [Abstract][Full Text] [Related]
19. Association of IgG anti-GD1a antibody with severe Guillain-Barré syndrome.
Yuki N; Yamada M; Sato S; Ohama E; Kawase Y; Ikuta F; Miyatake T
Muscle Nerve; 1993 Jun; 16(6):642-7. PubMed ID: 8502262
[TBL] [Abstract][Full Text] [Related]
20. Relationships between anti-ganglioside antibodies and clinical characteristics of Guillain-Barré syndrome.
Irie S; Saito T; Kanazawa N; Nukazawa T; Ito H; Ogino M; Kowa H
Intern Med; 1997 Sep; 36(9):607-12. PubMed ID: 9313102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
